Erratum for: Legal responses to new psychoactive substances in Europe: countries inside the REITOX network, Norway, and Türkiye.

Authors

Valeria Aquilina, Francesco Paolo Busardò, Simona Pichini, Giulia Bambagiotti, Silvia Graziano

Published in

Annali dell'Istituto superiore di sanita. Volume 62. Issue 3. Pages 292.

Abstract

Ann Ist Super Sanità 2026 | Vol. 62, No. 2: 100-114 DOI: 10.4415/ANN_26_02_02 In the originally published version of this manuscript, an error occurred in the third column of Table 1 (Italy drug scheduling section, page 105) reporting the drug scheduling for Italy. The correct drug scheduling should read: "The scheduling system classifies substances into five Tables: - Table I: substances with highest abuse potential (e.g., heroin, cocaine, amphetamines) - Table II: cannabis products (e.g. marijuana, hashish) - Table III: barbiturates - Table IV: benzodiazepines - Table medicinal products: medicinal products containing narcotic or psychotropic substances" instead of: The scheduling system classifies substances into five Tables: - Table I: substances with high abuse potential and no recognized medical use (e.g., heroin, LSD) - Table II: substances with high abuse potential but with recognized medical use (e.g., morphine, methadone) - Table III: substances with lower abuse potential and recognized medical use (e.g., codeine) - Table IV: preparations containing substances from Tables II and III in combinations that reduce abuse potential Table medicinal products: medicinal products containing narcotic or psychotropic substances in minimal quantities We apologize for this error and any confusion it may have caused.

PMID:
42742246
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.